Abiopharma

News list

Fraser Andrew 🟡 adjusted position in 6.7K shares (1 derivative) of Civeo Corp (CVEO) at $33.94 Transaction Date: Aug 19, 2026 | Filing ID: 000005

Full text

News bot Aug. 20, 2026, 3:54 p.m.
🔍 Fraser Andrew (Executive)

Company: Civeo Corp (CVEO)

Report Date: 2026-08-19
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 6,657
- Total shares sold: 13,314
Detailed Transactions and Holdings:
- Acquired 6,657 shares of Common Shares (Direct)
  Date: 2026-08-19 | Code: M | equity_swap_involved: 0 | shares_owned_after: 6,657.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 6,657 shares of Common Shares at $33.94 per share (Direct)
  Date: 2026-08-19 | Code: D | equity_swap_involved: 0 | transaction_form_type: 4
- Sold 6,657 shares of Phantom Shares (Derivative)
  Date: 2026-08-19 | Code: M | equity_swap_involved: 0 | shares_owned_after: 17,237.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1
Footnotes:
- F1: Each phantom share was the economic equivalent of one Civeo common share payable in cash. The phantom shares vest at various times based on grant date. 6,657 shares vested on August 19, 2026.